# Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT03919552** · PHASE3 · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 482 (estimated)

## Conditions studied

- Cisplatin
- Carboplatin
- NPC

## Interventions

- **DRUG:** Docetaxel,Carboplatin
- **DRUG:** Docetaxel,Cisplatin
- **RADIATION:** Carboplatin-based concurrent chemoradiotherapy
- **RADIATION:** Cisplatin-based concurrent chemoradiotherapy

## Key facts

- **NCT ID:** NCT03919552
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-31
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 482 (ESTIMATED)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919552, "Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03919552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*